However, to the best of our knowledge, no studies have been conducted on KP metabolites in cerebrospinal fluid (CSF), and the potentially neuroactive metabolites have not been measured, thus leaving unresolved the key issue of the potential for engagement of neuroactive KP metabolites with their targets in delirium. This evidence concerns the gene NPPA and delirium.